NCT04678063View on ClinicalTrials.gov

Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

June 15, 2017

Study Completion Date

July 11, 2017

Conditions
Allergic AsthmaAllergyAllergy to Cats
Interventions
OTHER

Exposure to Placebo

Patients are exposed to placebo in the EEC

OTHER

Exposure to dose A and dose B of cat allergen

Patients are exposed to dose A and B for successive exposures in the EEC

OTHER

Exposure to a single dose of cat allergen

Patients are exposed to a single dose of cat allergen in the EEC according to the dose selected to achieve the main objective (dose A or B)

Trial Locations (1)

67000

Alyatec, Strasbourg

Sponsors

Lead Sponsor

Alyatec
All Listed Sponsors
lead

Alyatec

INDUSTRY